However, these inhibitors decreased the levels of phosphorylated S6K and 4E-BP1 molecules of the mTOR pathway compared to vehicle treated neuroblastoma cell lines, suggesting that BI2536 and vismodegib can also target the mTOR signaling pathway. Here, RPS6KB1 is linked to neuroblastoma.